Quantum dots and prion proteins

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 1999; 402:822 - 6; http://dx.doi.org/10.1038/45574; PMID: 10617204
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prion diseases and the BSE crisis. Science 1997; 278:245 - 51; http://dx.doi.org/10.1126/science.278.5336.245; PMID: 9323196
   PubMed Web of Science ®Google Scholar
• Inge-Vechtomov SG, Zhouravleva GA, Chernoff YO. Biological roles of prion domains. Prion 2007; 1:228 - 35; http://dx.doi.org/10.4161/pri.1.4.5059; PMID: 19172114
   PubMed Web of Science ®Google Scholar
• Sobrova P, Ryvolova M, Hynek D, Adam V, Hubalek J, Kizek R. Electrochemical Behaviour of Native and Denatured beta-Sheet Breaker Prion Protein. Int J Electrochem Sci 2012; 7:928 - 42
   Web of Science ®Google Scholar
• Kozlowski H, Luczkowski M, Remelli M, Valensin D. Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases). Coord Chem Rev 2012; 256:2129 - 41; http://dx.doi.org/10.1016/j.ccr.2012.03.013
   Web of Science ®Google Scholar
• Viles JH. Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases. Coord Chem Rev 2012; 256:2271 - 84; http://dx.doi.org/10.1016/j.ccr.2012.05.003
   Web of Science ®Google Scholar
• Kessels HW, Nguyen LN, Nabavi S, Malinow R. The prion protein as a receptor for amyloid-beta. Nature 2010; 466:E3 - 4, discussion E4-5; http://dx.doi.org/10.1038/nature09217; PMID: 20703260
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Fowler DM, Kelly JW. Functional amyloidogenesis and cytotoxicity-insights into biology and pathology. PLoS Biol 2012; 10:e1001459; http://dx.doi.org/10.1371/journal.pbio.1001459; PMID: 23300381
   PubMedGoogle Scholar
• Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 1998; 96:116 - 22; http://dx.doi.org/10.1007/s004010050870; PMID: 9705125
   PubMed Web of Science ®Google Scholar
• Peden AH, Ironside JW. Molecular pathology in neurodegenerative diseases. Curr Drug Targets 2012; 13:1548 - 59; http://dx.doi.org/10.2174/138945012803530134; PMID: 22974397
   PubMed Web of Science ®Google Scholar
• van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YAL, van der Flier WM, Scheltens P. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 2011; 49:353 - 66; http://dx.doi.org/10.1515/CCLM.2011.086; PMID: 21342021
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med 2012; 16:1166 - 83; http://dx.doi.org/10.1111/j.1582-4934.2011.01507.x; PMID: 22176890
   PubMed Web of Science ®Google Scholar
• Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003; 62:885 - 98; PMID: 14533778
   PubMed Web of Science ®Google Scholar
• Kellett KAB, Hooper NM. Prion protein and Alzheimer disease. Prion 2009; 3:190 - 4; http://dx.doi.org/10.4161/pri.3.4.9980; PMID: 19887909
   PubMed Web of Science ®Google Scholar
• Parchi P, Strammiello R, Giese A, Kretzschmar H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol 2011; 121:91 - 112; http://dx.doi.org/10.1007/s00401-010-0779-6; PMID: 21107851
   PubMed Web of Science ®Google Scholar
• Soto C. Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2004; 2:809 - 19; http://dx.doi.org/10.1038/nrmicro1003; PMID: 15378045
   PubMed Web of Science ®Google Scholar
• Huzarewich RL, Siemens CG, Booth SA. Application of “omics” to prion biomarker discovery. J Biomed Biotechnol 2010; 2010:613504; http://dx.doi.org/10.1155/2010/613504; PMID: 20224650
   PubMed Web of Science ®Google Scholar
• Goldfarb LG, Cervenakova L, Gajdusek DC. Genetic studies in relation to kuru: an overview. Curr Mol Med 2004; 4:375 - 84; http://dx.doi.org/10.2174/1566524043360627; PMID: 15354868
   PubMed Web of Science ®Google Scholar
• Liberski PP. Kuru and D. Carleton Gajdusek: a close encounter. Folia Neuropathol 2009; 47:114 - 37; PMID: 19618335
   PubMed Web of Science ®Google Scholar
• Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM. Normal prion protein has an activity like that of superoxide dismutase. Biochem J 1999; 344:1 - 5; http://dx.doi.org/10.1042/0264-6021:3440001; PMID: 10548526
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157 - 65; http://dx.doi.org/10.1038/2654; PMID: 9771749
   PubMed Web of Science ®Google Scholar
• Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358:171 - 80; http://dx.doi.org/10.1016/S0140-6736(01)05403-4; PMID: 11476832
   PubMed Web of Science ®Google Scholar
• Peralta OA, Eyestone WH. Quantitative and qualitative analysis of cellular prion protein (PrP(C)) expression in bovine somatic tissues. Prion 2009; 3:161 - 70; http://dx.doi.org/10.4161/pri.3.3.9772; PMID: 19806026
   PubMed Web of Science ®Google Scholar
• Nunnally BK. It's a mad, mad, mad, mad cow: a review of analytical methodology for detecting BSE/TSE. Trac-Trends Anal Chem 2002; 21:82 - 9; http://dx.doi.org/10.1016/S0165-9936(01)00134-0
   Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M, Miele G. Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. J Clin Invest 2004; 114:153 - 60; PMID: 15254579
   PubMed Web of Science ®Google Scholar
• Grassi J, Maillet S, Simon S, Morel N. Progress and limits of TSE diagnostic tools. Vet Res 2008; 39:33; http://dx.doi.org/10.1051/vetres:2008009; PMID: 18284910
   PubMed Web of Science ®Google Scholar
• Miller JM, Jenny AL, Taylor WD, Marsh RF, Rubenstein R, Race RE. Immunohistochemical detection of prion protein in sheep with scrapie. J Vet Diagn Invest 1993; 5:309 - 16; http://dx.doi.org/10.1177/104063879300500301; PMID: 8104039
   PubMed Web of Science ®Google Scholar
• Zsolnai A, Anton I, Kühn C, Fésüs L. Detection of single-nucleotide polymorphisms coding for three ovine prion protein variants by primer extension assay and capillary electrophoresis. Electrophoresis 2003; 24:634 - 8; http://dx.doi.org/10.1002/elps.200390074; PMID: 12601731
   PubMed Web of Science ®Google Scholar
• Groschup MH, Weiland F, Straub OC. Diagnosis of bovine spongiform encephalopathy and scrapie - Possibilities and limitations of the diagnosis. Tierarztl Umsch 1994; 49:137 - 42
   Google Scholar
• Lacroux C, Bougard D, Litaise C, Simmons H, Corbiere F, Dernis D, Tardivel R, Morel N, Simon S, Lugan S, et al. Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission. PLoS One 2012; 7:e42019; http://dx.doi.org/10.1371/journal.pone.0042019; PMID: 22860049
   PubMedGoogle Scholar
• Zhuang HL, Zhen SJ, Wang J, Huang CZ. Sensitive detection of prion protein through long range resonance energy transfer between graphene oxide and molecular aptamer beacon. Anal Methods 2013; 5:208 - 12; http://dx.doi.org/10.1039/c2ay26156a
   Web of Science ®Google Scholar
• Atarashi R, Sano K, Satoh K, Nishida N. Real-time quaking-induced conversion: a highly sensitive assay for prion detection. Prion 2011; 5:150 - 3; http://dx.doi.org/10.4161/pri.5.3.16893; PMID: 21778820
   PubMed Web of Science ®Google Scholar
• Azam G, Shibata T, Kabashima T, Kai M. Sensitive chemiluminescence detection of prion protein on a membrane by using a peroxidase-labeled dextran probe. Anal Sci 2011; 27:715 - 20; http://dx.doi.org/10.2116/analsci.27.715; PMID: 21747179
   PubMed Web of Science ®Google Scholar
• Silva CJ, Onisko BC, Dynin I, Erickson ML, Requena JR, Carter JM. Utility of mass spectrometry in the diagnosis of prion diseases. Anal Chem 2011; 83:1609 - 15; http://dx.doi.org/10.1021/ac102527w; PMID: 21288014
   PubMed Web of Science ®Google Scholar
• Onisko B, Dynin I, Requena JR, Silva CJ, Erickson M, Carter JM. Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS. J Am Soc Mass Spectrom 2007; 18:1070 - 9; http://dx.doi.org/10.1016/j.jasms.2007.03.009; PMID: 17446085
   PubMed Web of Science ®Google Scholar
• Yang WC, Schmerr MJ, Jackman R, Bodemer W, Yeung ES. Capillary electrophoresis-based noncompetitive immunoassay for the prion protein using fluorescein-labeled protein A as a fluorescent probe. Anal Chem 2005; 77:4489 - 94; http://dx.doi.org/10.1021/ac050231u; PMID: 16013864
   PubMed Web of Science ®Google Scholar
• Yang WC, Yeung ES, Schmerr MJ. Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorescence detection and cyclodextrin-aided separation. Electrophoresis 2005; 26:1751 - 9; http://dx.doi.org/10.1002/elps.200410202; PMID: 15815999
   PubMed Web of Science ®Google Scholar
• Chang BG, Gray P, Piltch M, Bulgin MS, Sorensen-Melson S, Miller MW, Davies P, Brown DR, Coughlin DR, Rubenstein R. Surround optical fiber immunoassay (SOFIA): an ultra-sensitive assay for prion protein detection. J Virol Methods 2009; 159:15 - 22; http://dx.doi.org/10.1016/j.jviromet.2009.02.019; PMID: 19442839
   PubMed Web of Science ®Google Scholar
• Reuter T, Gilroyed BH, Alexander TW, Mitchell G, Balachandran A, Czub S, McAllister TA. Prion protein detection via direct immuno-quantitative real-time PCR. J Microbiol Methods 2009; 78:307 - 11; http://dx.doi.org/10.1016/j.mimet.2009.07.001; PMID: 19596031
   PubMed Web of Science ®Google Scholar
• Dabaghian RH, Barnard G, McConnell I, Clewley JP. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry. J Virol Methods 2006; 132:85 - 91; http://dx.doi.org/10.1016/j.jviromet.2005.09.002; PMID: 16219367
   PubMed Web of Science ®Google Scholar
• Brooks B, Brooks A, Wulff SS, Lewis RV. Identification of problems developing an ultrasensitive immunoassay for the ante mortem detection of the infectious isoform of the CWD-associated prion protein. J Immunoassay Immunochem 2009; 30:135 - 49; http://dx.doi.org/10.1080/15321810902782848; PMID: 19330640
   PubMed Web of Science ®Google Scholar
• Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, Prusiner SB. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A 2007; 104:20914 - 9; http://dx.doi.org/10.1073/pnas.0710152105; PMID: 18096717
   PubMed Web of Science ®Google Scholar
• Chang BG, Cheng X, Yin SM, Pan T, Zhang HT, Wong PK, Kang SC, Xiao F, Yan HM, Li CY, et al. Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin Vaccine Immunol 2007; 14:36 - 43; http://dx.doi.org/10.1128/CVI.00341-06; PMID: 17079434
   PubMed Web of Science ®Google Scholar
• Trieschmann L, Navarrete Santos A, Kaschig K, Torkler S, Maas E, Schätzl H, Böhm G. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. BMC Biotechnol 2005; 5:26; http://dx.doi.org/10.1186/1472-6750-5-26; PMID: 16202155
   PubMed Web of Science ®Google Scholar
• Xiao SJ, Hu PP, Li YF, Huang CZ, Huang T, Xiao GF. Aptamer-mediated turn-on fluorescence assay for prion protein based on guanine quenched fluophor. Talanta 2009; 79:1283 - 6; http://dx.doi.org/10.1016/j.talanta.2009.05.040; PMID: 19635360
   PubMed Web of Science ®Google Scholar
• Henry J, Anand A, Chowdhury M, Coté G, Moreira R, Good T. Development of a nanoparticle-based surface-modified fluorescence assay for the detection of prion proteins. Anal Biochem 2004; 334:1 - 8; http://dx.doi.org/10.1016/j.ab.2004.07.008; PMID: 15464948
   PubMed Web of Science ®Google Scholar
• Huang XX, Long YJ, Zhang HJ, Wang QL, Zhu R, Zheng HZ. Gold nanoparticles as a probe for prion determination via resonance light scattering method. Anal Sci 2012; 28:475 - 9; http://dx.doi.org/10.2116/analsci.28.475; PMID: 22687927
   PubMed Web of Science ®Google Scholar
• Ugnon-Café S, Dorey A, Bilheude JM, Streichenberger N, Viennet G, Meyronet D, Maues de Paula A, Perret-Liaudet A, Quadrio I. Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease. J Virol Methods 2011; 175:216 - 23; http://dx.doi.org/10.1016/j.jviromet.2011.05.016; PMID: 21619894
   PubMed Web of Science ®Google Scholar
• Warwick RM, Armitage WJ, Chandrasekar A, Mallinson G, Poniatowski S, Clarkson A. A pilot to examine the logistical and feasibility issues in testing deceased tissue donors for vCJD using tonsil as the analyte. Cell Tissue Bank 2012; 13:53 - 61; http://dx.doi.org/10.1007/s10561-010-9228-y; PMID: 21046259
   PubMed Web of Science ®Google Scholar
• Dong CF, Huang YX, An R, Chen JM, Wang XF, Shan B, Lei YJ, Han L, Zhang BY, Han J, et al. Sensitive detection of PrPSc by Western blot assay based on streptomycin sulphate precipitation. Zoonoses Public Health 2007; 54:328 - 36; http://dx.doi.org/10.1111/j.1863-2378.2007.01062.x; PMID: 17894644
   PubMed Web of Science ®Google Scholar
• Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377:487 - 93; http://dx.doi.org/10.1016/S0140-6736(10)62308-2; PMID: 21295339
   PubMed Web of Science ®Google Scholar
• Rubenstein R, Gray PC, Wehlburg CM, Wagner JS, Tisone GC. Detection and discrimination of PrPSc by multi-spectral ultraviolet fluorescence. Biochem Biophys Res Commun 1998; 246:100 - 6; http://dx.doi.org/10.1006/bbrc.1998.8542; PMID: 9600075
   PubMed Web of Science ®Google Scholar
• Birkmann E, Schäfer O, Weinmann N, Dumpitak C, Beekes M, Jackman R, Thorne L, Riesner D. Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion. Biol Chem 2006; 387:95 - 102; http://dx.doi.org/10.1515/BC.2006.013; PMID: 16497169
   PubMed Web of Science ®Google Scholar
• Fujii F, Horiuchi M, Ueno M, Sakata H, Nagao I, Tamura M, Kinjo M. Detection of prion protein immune complex for bovine spongiform encephalopathy diagnosis using fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy. Anal Biochem 2007; 370:131 - 41; http://dx.doi.org/10.1016/j.ab.2007.07.018; PMID: 17825783
   PubMed Web of Science ®Google Scholar
• Lodi R, Parchi P, Tonon C, Manners D, Capellari S, Strammiello R, Rinaldi R, Testa C, Malucelli E, Mostacci B, et al. Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 2009; 132:2669 - 79; http://dx.doi.org/10.1093/brain/awp210; PMID: 19755520
   PubMed Web of Science ®Google Scholar
• Galanaud D, Haik S, Linguraru MG, Ranjeva JP, Faucheux B, Kaphan E, Ayache N, Chiras J, Cozzone P, Dormont D, et al. Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases. AJNR Am J Neuroradiol 2010; 31:1311 - 8; http://dx.doi.org/10.3174/ajnr.A2069; PMID: 20430851
   PubMed Web of Science ®Google Scholar
• Murray KL, Knight RSG, Summers D, Collie DAC, Will RG. The role of MRI brain scan in the diagnosis of human prion disease. J Neurol Neurosurg Psychiatry 2005; 76:608
   Web of Science ®Google Scholar
• Lasch P, Schmitt J, Beekes M, Udelhoven T, Eiden M, Fabian H, Petrich W, Naumann D. Antemortem identification of bovine spongiform encephalopathy from serum using infrared spectroscopy. Anal Chem 2003; 75:6673 - 8; http://dx.doi.org/10.1021/ac030259a; PMID: 14640744
   PubMed Web of Science ®Google Scholar
• Beekes M, Lasch P, Naumann D. Analytical applications of Fourier transform-infrared (FT-IR) spectroscopy in microbiology and prion research. Vet Microbiol 2007; 123:305 - 19; http://dx.doi.org/10.1016/j.vetmic.2007.04.010; PMID: 17540519
   PubMed Web of Science ®Google Scholar
• Alvarez-Puebla RA, Agarwal A, Manna P, Khanal BP, Aldeanueva-Potel P, Carbó-Argibay E, Pazos-Pérez N, Vigderman L, Zubarev ER, Kotov NA, et al. Gold nanorods 3D-supercrystals as surface enhanced Raman scattering spectroscopy substrates for the rapid detection of scrambled prions. Proc Natl Acad Sci U S A 2011; 108:8157 - 61; http://dx.doi.org/10.1073/pnas.1016530108; PMID: 21536908
   PubMed Web of Science ®Google Scholar
• Castilla J, Saa P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. In: Kheterpal I, Wetzel R, eds. Amyloid, Prions, and Other Protein Aggregates, Pt B. San Diego: Elsevier Academic Press Inc, 2006:3-21.
   Google Scholar
• Saá P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 2006; 281:35245 - 52; http://dx.doi.org/10.1074/jbc.M603964200; PMID: 16982620
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 3; http://dx.doi.org/10.1038/35081095; PMID: 11459061
   PubMed Web of Science ®Google Scholar
• Soto C, Anderes L, Suardi S, Cardone F, Castilla J, Frossard MJ, Peano S, Saa P, Limido L, Carbonatto M, et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005; 579:638 - 42; http://dx.doi.org/10.1016/j.febslet.2004.12.035; PMID: 15670821
   PubMed Web of Science ®Google Scholar
• Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer’s disease. J Neurosci 2001; 21:RC189; PMID: 11734604
   PubMed Web of Science ®Google Scholar
• Cai LS, Chin FT, Pike VW, Toyama H, Liow JS, Zoghbi SS, Modell K, Briard E, Shetty HU, Sinclair K, et al. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4′-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer’s disease. J Med Chem 2004; 47:2208 - 18; http://dx.doi.org/10.1021/jm030477w; PMID: 15084119
   PubMed Web of Science ®Google Scholar
• Klunk WE, Wang YM, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, Mathis CA. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 2003; 23:2086 - 92; PMID: 12657667
   PubMed Web of Science ®Google Scholar
• Mastrianni JA. Prion diseases. Clin Neurosci Res 2004; 3:469 - 80; http://dx.doi.org/10.1016/j.cnr.2004.04.012
   Web of Science ®Google Scholar
• Ono M, Saji H. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer’s disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer’s disease. J Pharmacol Sci 2012; 118:338 - 44; http://dx.doi.org/10.1254/jphs.11R08FM; PMID: 22382657
   PubMed Web of Science ®Google Scholar
• Verhoeff NP, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 2004; 12:584 - 95; PMID: 15545326
   PubMed Web of Science ®Google Scholar
• Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer’s disease patients. J Nucl Med 2007; 48:553 - 61; http://dx.doi.org/10.2967/jnumed.106.037556; PMID: 17401091
   PubMed Web of Science ®Google Scholar
• Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JAM, Juréus A, Ström P, Norman H, Farde L, Svensson SPS. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. J Neurochem 2009; 108:1177 - 86; http://dx.doi.org/10.1111/j.1471-4159.2008.05861.x; PMID: 19141073
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Xu CL, Li BX. Simple and sensitive detection method for chromium(VI) in water using glutathione-capped CdTe quantum dots as fluorescent probes. Mikrochim Acta 2009; 166:61 - 8; http://dx.doi.org/10.1007/s00604-009-0164-0
   Web of Science ®Google Scholar
• Li T, Zhou YY, Sun JY, Tang DB, Guo SX, Ding XP. Ultrasensitive detection of mercury(II) ion using CdTe quantum dots in sol-gel-derived silica spheres coated with calix 6 arene as fluorescent probes. Mikrochim Acta 2011; 175:113 - 9; http://dx.doi.org/10.1007/s00604-011-0655-7
   Web of Science ®Google Scholar
• Li YL, Zhou J, Liu CL, Li HB. Composite quantum dots detect Cd(II) in living cells in a fluorescence “turning on” mode. J Mater Chem 2012; 22:2507 - 11; http://dx.doi.org/10.1039/c1jm14317d
   Web of Science ®Google Scholar
• Algar WR, Tavares AJ, Krull UJ. Beyond labels: a review of the application of quantum dots as integrated components of assays, bioprobes, and biosensors utilizing optical transduction. Anal Chim Acta 2010; 673:1 - 25; http://dx.doi.org/10.1016/j.aca.2010.05.026; PMID: 20630173
   PubMed Web of Science ®Google Scholar
• Chen JA, Pei Y, Chen ZW, Cai JY. Quantum dot labeling based on near-field optical imaging of CD44 molecules. Micron 2010; 41:198 - 202; http://dx.doi.org/10.1016/j.micron.2009.11.002; PMID: 19959369
   PubMed Web of Science ®Google Scholar
• Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 2008; 5:763 - 75; http://dx.doi.org/10.1038/nmeth.1248; PMID: 18756197
   PubMed Web of Science ®Google Scholar
• Das P, Zhong WH, Claverie JP. Copolymer nanosphere encapsulated CdS quantum dots prepared by RAFT copolymerization: synthesis, characterization and mechanism of formation. Colloid Polym Sci 2011; 289:1519 - 33; http://dx.doi.org/10.1007/s00396-011-2466-0
   Web of Science ®Google Scholar
• Kumar KS, Divya A, Reddy PS. Synthesis and characterization of Cr doped CdS nanoparticles stabilized with polyvinylpyrrolidone. Appl Surf Sci 2011; 257:9515 - 8; http://dx.doi.org/10.1016/j.apsusc.2011.06.048
   Web of Science ®Google Scholar
• Gondal MA, Bagabas AA, Dastageer MA. Synthesis of w-CdS quantum dots and discovery of intense sub band emission owing to longitudinal optical phonons. J Nanopart Res 2011; 13:3835 - 42; http://dx.doi.org/10.1007/s11051-011-0318-y
   Web of Science ®Google Scholar
• Gu Y, Kuskovsky IL, Fung J, Robinson R, Herman IP, Neumark GF, Zhou X, Guo SP, Tamargo MC. Determination of size and composition of optically active CdZnSe/ZnBeSe quantum dots. Appl Phys Lett 2003; 83:3779 - 81; http://dx.doi.org/10.1063/1.1623941
   Web of Science ®Google Scholar
• Rameshwar T, Samal S, Lee S, Kim S, Cho J, Kim IS. Determination of the size of water-soluble nanoparticles and quantum dots by field-flow fractionation. J Nanosci Nanotechnol 2006; 6:2461 - 7; http://dx.doi.org/10.1166/jnn.2006.544; PMID: 17037856
   PubMed Web of Science ®Google Scholar
• Lin ZH, Wang MQ, Wei LZ, Song XH, Xue YH, Yao X. Synthesis and characterization of ZnSe/ZnS core/shell nanocrystals by aqueous reflux route. J Alloy Comp 2011; 509:8356 - 9; http://dx.doi.org/10.1016/j.jallcom.2011.03.070
   Web of Science ®Google Scholar
• Huang FH, Lan YL, Chen PF. Synthesis and characterization of water-soluble l-cysteine-modified ZnS nanocrystals doped with silver. J Mater Sci 2011; 46:5732 - 6; http://dx.doi.org/10.1007/s10853-011-5527-3
   Web of Science ®Google Scholar
• Khene S, Moeno S, Nyokong T. Voltammetry and electrochemical impedance spectroscopy of gold electrodes modified with CdTe quantum dots and their conjugates with nickel tetraamino phthalocyanine. Polyhedron 2011; 30:2162 - 70; http://dx.doi.org/10.1016/j.poly.2011.06.002
   Web of Science ®Google Scholar
• Li YF, Han M, Bai HY, Wu Y, Dai ZH, Bao JC. A sensitive electrochemical aptasensor based on water soluble CdSe quantum dots (QDs) for thrombin determination. Electrochim Acta 2011; 56:7058 - 63; http://dx.doi.org/10.1016/j.electacta.2011.05.119
   Web of Science ®Google Scholar
• Wang QS, Yang L, Fang TT, Wu S, Liu P, Min XM, Li X. Interactions between CdSe/CdS quantum dots and DNA through spectroscopic and electrochemical methods. Appl Surf Sci 2011; 257:9747 - 51; http://dx.doi.org/10.1016/j.apsusc.2011.05.123
   Web of Science ®Google Scholar
• Ghaderi S, Ramesh B, Seifalian AM. Fluorescence nanoparticles “quantum dots” as drug delivery system and their toxicity: a review. J Drug Target 2011; 19:475 - 86; http://dx.doi.org/10.3109/1061186X.2010.526227; PMID: 20964619
   PubMed Web of Science ®Google Scholar
• Hoshino A, Hanada S, Yamamoto K. Toxicity of nanocrystal quantum dots: the relevance of surface modifications. Arch Toxicol 2011; 85:707 - 20; http://dx.doi.org/10.1007/s00204-011-0695-0; PMID: 21445587
   PubMed Web of Science ®Google Scholar
• Pelley JL, Daar AS, Saner MA. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci 2009; 112:276 - 96; http://dx.doi.org/10.1093/toxsci/kfp188; PMID: 19684286
   PubMed Web of Science ®Google Scholar
• Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006; 114:165 - 72; http://dx.doi.org/10.1289/ehp.8284; PMID: 16451849
   PubMed Web of Science ®Google Scholar
• Ryvolova M, Chomoucka J, Janu L, Drbohlavova J, Adam V, Hubalek J, Kizek R. Biotin-modified glutathione as a functionalized coating for bioconjugation of CdTe-based quantum dots. Electrophoresis 2011; 32:1619 - 22; PMID: 21607989
   PubMed Web of Science ®Google Scholar
• Bottini M, Cerignoli F, Dawson MI, Magrini A, Rosato N, Mustelin T. Full-length single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots as multivalent intracellular fluorescent nanoprobes. Biomacromolecules 2006; 7:2259 - 63; http://dx.doi.org/10.1021/bm0602031; PMID: 16903668
   PubMed Web of Science ®Google Scholar
• Shao J, You XG, Gao F, He R, Cui DX. Labeling of quantum dots with streptavidin and its bioactivity measurement. Chin J Anal Chem 2006; 34:1625 - 8
   Web of Science ®Google Scholar
• Wu Y, Lopez GP, Sklar LA, Buranda T. Spectroscopic characterization of streptavidin functionalized quantum dots. Anal Biochem 2007; 364:193 - 203; http://dx.doi.org/10.1016/j.ab.2007.02.007; PMID: 17368555
   PubMed Web of Science ®Google Scholar
• Bruchez M Jr., Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998; 281:2013 - 6; http://dx.doi.org/10.1126/science.281.5385.2013; PMID: 9748157
   PubMed Web of Science ®Google Scholar
• Chan WCW, Nie SM. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998; 281:2016 - 8; http://dx.doi.org/10.1126/science.281.5385.2016; PMID: 9748158
   PubMed Web of Science ®Google Scholar
• Pellegrino T, Manna L, Kudera S, Liedl T, Koktysh D, Rogach AL, Keller S, Radler J, Natile G, Parak WJ. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: A general route to water soluble nanocrystals. Nano Lett 2004; 4:703 - 7; http://dx.doi.org/10.1021/nl035172j
   Web of Science ®Google Scholar
• Fernandez-Argüelles MT, Yakovlev A, Sperling RA, Luccardini C, Gaillard S, Medel AS, Mallet JM, Brochon JC, Feltz A, Oheim M, et al. Synthesis and characterization of polymer-coated quantum dots with integrated acceptor dyes as FRET-based nanoprobes. Nano Lett 2007; 7:2613 - 7; http://dx.doi.org/10.1021/nl070971d; PMID: 17691850
   PubMed Web of Science ®Google Scholar
• Lin CAJ, Sperling RA, Li JK, Yang TY, Li PY, Zanella M, Chang WH, Parak WJ. Design of an amphiphilic polymer for nanoparticle coating and functionalization. Small 2008; 4:334 - 41; http://dx.doi.org/10.1002/smll.200700654; PMID: 18273855
   PubMed Web of Science ®Google Scholar
• Alivisatos AP. Birth of a nanoscience building block. ACS Nano 2008; 2:1514 - 6; http://dx.doi.org/10.1021/nn800485f; PMID: 19206353
   PubMed Web of Science ®Google Scholar
• Sobrova P, Ryvolova M. J. H, Adam V, Kizek R. Femtogram Electrochemical Sensing of Prion Proteins Using Quantum Dots. Anal Chim Acta 2013; Submitted
   Google Scholar
• Duan JL, Song LX, Zhan JH. One-Pot Synthesis of Highly Luminescent CdTe Quantum Dots by Microwave Irradiation Reduction and Their Hg(2+)-Sensitive Properties. Nano Res 2009; 2:61 - 8; http://dx.doi.org/10.1007/s12274-009-9004-0
   Web of Science ®Google Scholar
• Dalal V, Bhattacharya M, Narang D, Sharma PK, Mukhopadhyay S. Nanoscale Fluorescence Imaging of Single Amyloid Fibrils. J Phys Chem Lett 2012; 3:1783 - 7; http://dx.doi.org/10.1021/jz300687f
   PubMed Web of Science ®Google Scholar
• Zhou YW, Li CM, Liu Y, Huang CZ. Effective detection and cell imaging of prion protein with new prepared targetable yellow-emission silver nanoclusters. Analyst 2013; 138:873 - 8; http://dx.doi.org/10.1039/c2an36456e; PMID: 23223184
   PubMed Web of Science ®Google Scholar
• Gao XH, Yang LL, Petros JA, Marshall FF, Simons JW, Nie SM. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005; 16:63 - 72; http://dx.doi.org/10.1016/j.copbio.2004.11.003; PMID: 15722017
   PubMed Web of Science ®Google Scholar
• Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307:538 - 44; http://dx.doi.org/10.1126/science.1104274; PMID: 15681376
   PubMed Web of Science ®Google Scholar
• Smith AM, Duan HW, Mohs AM, Nie SM. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 2008; 60:1226 - 40; http://dx.doi.org/10.1016/j.addr.2008.03.015; PMID: 18495291
   PubMed Web of Science ®Google Scholar
• Hu R, Zhang XB, Kong RM, Zhao XH, Jiang JH, Tan WH. Nucleic acid-functionalized nanomaterials for bioimaging applications. J Mater Chem 2011; 21:16323 - 34; http://dx.doi.org/10.1039/c1jm12588e
   Web of Science ®Google Scholar
• Taniguchi S, Green M, Rizvi SB, Seifalian A. The one-pot synthesis of core/shell/shell CdTe/CdSe/ZnSe quantum dots in aqueous media for in vivo deep tissue imaging. J Mater Chem 2011; 21:2877 - 82; http://dx.doi.org/10.1039/c0jm03527k
   Web of Science ®Google Scholar
• Ciarlo M, Russo P, Cesario A, Ramella S, Baio G, Neumaier CE, Paleari L. Use of the semiconductor nanotechnologies “quantum dots” for in vivo cancer imaging. Recent Pat Anticancer Drug Discov 2009; 4:207 - 15; http://dx.doi.org/10.2174/157489209789206841; PMID: 19715554
   PubMed Web of Science ®Google Scholar
• Tavares AJ, Chong LR, Petryayeva E, Algar WR, Krull UJ. Quantum dots as contrast agents for in vivo tumor imaging: progress and issues. Anal Bioanal Chem 2011; 399:2331 - 42; http://dx.doi.org/10.1007/s00216-010-4010-3; PMID: 20658228
   PubMed Web of Science ®Google Scholar
• Jetha NN, Semenchenko V, Wishart DS, Cashman NR, Marziali A. Nanopore Analysis of Wild-Type and Mutant Prion Protein (PrPC): Single Molecule Discrimination and PrPC Kinetics. PLoS ONE 2013; 8:1 - 10; http://dx.doi.org/10.1371/journal.pone.0054982
   Web of Science ®Google Scholar